The SEC62 gene, also known as TLOC1, is located on chromosome 3q26 . The mammalian Sec62 protein resides in the ER membrane and contains two transmembrane helices, a short ER-lumenal loop, and two large cytosolic domains . Sec62 forms a heterodimeric complex with the Sec63 protein and transiently associates with the heterotrimeric Sec61 complex . These interactions involve a positively charged patch of amino acid residues in the N-terminal domain of Sec62 plus a negatively charged cluster at the C-terminus of Sec63 and the C-terminal domain of Sec62 (including two predicted EF hands) plus the N-terminus of Sec61α, respectively .
Sec62 is involved in the translocation and membrane insertion of proteins with diverse sequence contexts, including variations in hydrophobicity, the number of transmembrane segments, flanking charged residues, and different membrane orientations . Sec62 is necessary in the SRP-independent translocation pathway . Sec62 facilitates the translocation of the C-terminus of membrane proteins and plays a role in the topogenesis of membrane proteins in the ER .
Sec62 is crucial for the efficient translocation of small proteins with N-terminal signal sequences . Specifically, proteins shorter than 160 amino acids rely on Sec62 for maximal translocation efficiency, whereas longer proteins depend on the signal recognition particle (SRP) . This suggests that the Sec62 pathway acts as a fail-safe route for small preproteins, ensuring their efficient secretion regardless of the SRP pathway .
Elevated Sec62 protein levels have been found in tumor tissue compared to tumor-free tissue in 53 breast cancer patients .
SEC62 copy number gains have been identified in prostate cancer samples, along with elevated Sec62 protein levels in prostate cancer cell lines . Overexpression of SEC62 is associated with prostate cancer progression, increasing ER stress tolerance and promoting migratory and invasive potential in prostate cancer cells . Sec62 has been proposed as a potential diagnostic marker and therapeutic target in prostate cancer . Similar observations have been made for non-small cell lung cancer (NSCLC) and thyroid cancer .
Systematic mutagenesis of Sec62 has been performed to assess its role in translocation and membrane insertion . Mutations in the N-terminal cytosolic domain of Sec62 disrupt its interaction with Sec63, leading to defects in the translocation of moderately hydrophobic transmembrane segments in both single- and multi-spanning membrane proteins . Studies using mutant strains have demonstrated that a defective Sec62-Sec63 complex impairs the membrane insertion of moderately hydrophobic transmembrane domains, as well as transmembrane domains with charged flanking residues .
SEC62 is a component of the Sec62-Sec63 complex that primarily functions as a mediator of post-translational translocation of proteins into the endoplasmic reticulum (ER). It was traditionally thought to handle mainly secretory proteins rather than membrane proteins . The protein contains transmembrane domains that anchor it in the ER membrane, with a cytosolic N-terminal domain that interacts with other components of the translocation machinery, particularly SEC63 . This interaction is critical for the proper functioning of the complex in protein translocation events.
SEC62 contains multiple domains that contribute to its function in protein translocation:
N-terminal cytosolic domain: Critical for interaction with SEC63 and proper translocation function
Transmembrane domains: Anchor the protein in the ER membrane
C-terminal domain: Contains functional elements involved in substrate recognition
Mutations in the N-terminal cytosolic domain can impair SEC62's interaction with SEC63, leading to defects in membrane insertion and translocation of the C-terminus of membrane proteins . This structural organization is essential for understanding how SEC62 contributes to protein translocation and membrane protein topogenesis.
While SEC62's basic function in post-translational translocation is conserved across species, there are notable differences in its role between yeast and mammalian systems:
| Parameter | Yeast SEC62 | Mammalian SEC62 |
|---|---|---|
| Primary pathway | Post-translational only | Post-translational and membrane protein insertion |
| Substrate specificity | Primarily secretory proteins | Broader range including membrane proteins |
| Associated complexes | Strictly with SEC63 | More diverse interactions |
| Regulation | Less complex | Involved in ER stress responses and homeostasis |
Recent research has uncovered that, contrary to previous assumptions, SEC62 in yeast plays an important role in membrane protein insertion and the regulation of membrane protein topogenesis . This represents a significant expansion of our understanding of SEC62 function beyond its classical role.
SEC62 has a newly discovered role in regulating ER turnover during recovery from stress. This function is particularly enhanced after the successful resolution of ER stress and contributes to re-establishing pre-stress ER homeostasis . The protein appears to participate in a process that helps clear ER components through autophagy after stress resolution, a process sometimes referred to as "recovER-phagy."
While SEC62 was traditionally associated exclusively with post-translational translocation of secretory proteins, systematic analysis has revealed its unexpected role in membrane protein insertion and topogenesis . Specifically:
SEC62 contributes to the proper membrane insertion of both single and multi-spanning membrane proteins
It helps regulate the orientation of transmembrane segments with varying properties (hydrophobicity, flanking charged residues)
Mutations in SEC62, particularly in its N-terminal domain, can lead to defects in membrane insertion and C-terminal translocation of membrane proteins
This represents a paradigm shift in our understanding of SEC62 function, as it indicates that the Sec62-Sec63 translocon has a broader role in eukaryotic cells than previously thought.
Studies using SEC62 knockout cell lines have demonstrated that SEC62 significantly impacts cell proliferation and migration:
SEC62 knockout in head and neck squamous cell carcinoma (HNSCC) cell lines results in markedly reduced proliferation rates compared to wild-type cells
Migration potential is substantially decreased in SEC62 knockout cells
The migratory and proliferative effects appear to be directly related to SEC62 function rather than secondary consequences
These findings suggest that SEC62 may represent a potential therapeutic target in cancers where cell migration and proliferation are key drivers of disease progression. The exact molecular mechanisms connecting SEC62's translocation function to these cellular processes remain an active area of investigation.
Creating effective SEC62 knockout models requires careful consideration of methodological approaches. Based on published research, the following protocol has proven effective:
CRISPR/Cas9 approach:
Design gRNA targeting SEC62 (e.g., sequence 5'-CTG TGG TTG ACT ACT GCA AC-3')
Transfect cells with lentiCRISPRv2-puro system containing the gRNA
Select transfected cells using puromycin (1.5 μg/ml)
Culture cells for approximately 5 days under selection pressure
Separate cells in low numbers (1000-2000 cells) for single cell isolation
Allow colonies to form (approximately 12 weeks)
Harvest colonies and conduct a second single cell clone selection step
Culture selected cells for an additional 8 weeks until monoclonal colonies form
Validation approaches:
In published studies, successful SEC62 knockout has been validated by NGS showing that 88-92% of sequencing reads differed from the reference genome, with most containing insertions or deletions near the PAM sequence . At the protein level, western blot analysis showed nearly undetectable SEC62 (3-4% of wild-type levels) .
Several well-established assays can be employed to evaluate SEC62 function:
These assays provide complementary information about SEC62 function in different cellular contexts. For example, the translocation assay directly measures SEC62's classical function, while the proliferation and migration assays capture its broader physiological roles .
To properly investigate SEC62's function in ER stress recovery, researchers should consider the following experimental design principles:
Stress induction and recovery protocol:
Apply appropriate ER stressors (e.g., tunicamycin, thapsigargin) at effective concentrations
Allow sufficient time for stress adaptation (typically 16-24 hours)
Remove stressor and allow recovery phase (4-24 hours)
Analyze SEC62-dependent processes during the recovery phase specifically
Key controls and comparisons:
Critical measurements:
Accumulation of ER markers in Lamp1-positive vesicles
Use of lysosomal inhibitors (e.g., Bafilomycin A1) to prevent degradation and enhance visualization
Protein translocation efficiency before, during, and after stress
ER morphology and turnover rates
Published research demonstrates that SEC62 is particularly important during the recovery phase, as evidenced by the accumulation of ER marker proteins in Lamp1-positive vesicles only in cells expressing functional SEC62 . This suggests that SEC62 plays a specific role in targeting ER components for degradation after stress resolution.
Despite significant advances in our understanding of SEC62, several important questions remain:
How does SEC62 mechanistically contribute to membrane protein topogenesis beyond its role in the Sec62-Sec63 translocon?
What is the molecular basis for SEC62's role in cell proliferation and migration?
How is SEC62 function regulated during different cellular states and stress conditions?
What is the complete repertoire of SEC62 interaction partners and substrates?
How do post-translational modifications of SEC62 affect its various functions?
Addressing these questions will require integrative approaches combining structural biology, proteomics, and advanced cellular imaging techniques.
Several cutting-edge technologies hold particular promise for advancing our understanding of SEC62:
| Technology | Application to SEC62 Research | Potential Insights |
|---|---|---|
| Cryo-electron microscopy | Structural analysis of SEC62 in complex with interaction partners | Molecular mechanisms of SEC62 function |
| Proximity labeling proteomics | Identification of SEC62 interaction networks | Novel functions and regulatory pathways |
| Live-cell imaging with optogenetic tools | Real-time visualization of SEC62 dynamics | Spatial and temporal regulation of SEC62 activities |
| Single-cell transcriptomics/proteomics | Cell-specific effects of SEC62 perturbation | Heterogeneity in SEC62 function across cell types |
| CRISPR screens with SEC62 domain mutants | Systematic functional analysis | Structure-function relationships |
These approaches will help resolve the current gaps in our understanding of SEC62 biology and potentially reveal new therapeutic opportunities targeting SEC62-dependent processes.